Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Proton radiotherapy for prostate cancer: how did we get here, and where do we go from here?

Yu JB, Efstathiou JA, Bekelman JE.

Oncology (Williston Park). 2013 Dec;27(12):1293-4. No abstract available.

2.

Re: Proton vs intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.

Schild SE, Keole SR, Foote RL.

J Natl Cancer Inst. 2013 May 15;105(10):748. doi: 10.1093/jnci/djt074. No abstract available.

PMID:
23559544
3.

Pushing the limits of radiation therapy for prostate cancer: where do we go next?

Mishra MV, Showalter TN.

Semin Oncol. 2013 Jun;40(3):297-307. doi: 10.1053/j.seminoncol.2013.04.005. Review.

PMID:
23806495
4.

Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?

Gray PJ, Efstathiou JA.

Curr Urol Rep. 2013 Jun;14(3):199-208. doi: 10.1007/s11934-013-0320-2. Review.

PMID:
23546839
5.

Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.

Rechner LA, Howell RM, Zhang R, Etzel C, Lee AK, Newhauser WD.

Phys Med Biol. 2012 Nov 7;57(21):7117-32. doi: 10.1088/0031-9155/57/21/7117.

6.

Protons for prostate cancer: the dream versus the reality.

Lawrence TS, Feng M.

J Natl Cancer Inst. 2013 Jan 2;105(1):7-8. doi: 10.1093/jnci/djs509. No abstract available.

PMID:
23243201
7.

Contemporary issues in radiotherapy for clinically localized prostate cancer.

Khor R, Williams S.

Hematol Oncol Clin North Am. 2013 Dec;27(6):1137-62, vii. doi: 10.1016/j.hoc.2013.08.006. Review.

PMID:
24188256
8.

Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer.

Pearlstein KA, Chen RC.

Semin Radiat Oncol. 2013 Jul;23(3):182-90. doi: 10.1016/j.semradonc.2013.01.004. Review.

PMID:
23763884
9.

Proton therapy for prostate cancer: time for evidence.

The Lancet Oncology.

Lancet Oncol. 2014 Jul;15(8):775. doi: 10.1016/S1470-2045(14)70304-3. No abstract available.

PMID:
24988919
10.

Prostate treatments in play. Proton-beam therapy fails to deliver better care.

Lee J, McKinney M, Evans M, Robeznieks A.

Mod Healthc. 2012 Dec 17;42(51):4. No abstract available.

PMID:
23323344
11.

Proton beam therapy and localised prostate cancer: current status and controversies.

Efstathiou JA, Gray PJ, Zietman AL.

Br J Cancer. 2013 Apr 2;108(6):1225-30. doi: 10.1038/bjc.2013.100. Review.

12.

JAMA patient page. Proton beam therapy for prostate cancer.

Sugerman DT, Livingston EH.

JAMA. 2014 Apr 9;311(14):1462. doi: 10.1001/jama.2014.1016. No abstract available.

PMID:
24715088
13.

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.

Kil WJ, Nichols RC Jr, Hoppe BS, Morris CG, Marcus RB Jr, Mendenhall W, Mendenhall NP, Li Z, Costa JA, Williams CR, Henderson RH.

Acta Oncol. 2013 Apr;52(3):492-7. doi: 10.3109/0284186X.2013.767983.

15.

Can you tell me the pros and cons of brachytherapy versus external-beam therapy versus surgery for prostate cancer?

[No authors listed]

Duke Med Health News. 2013 Aug;19(8):8. No abstract available.

PMID:
23984455
16.

Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan.

Nihei K, Ogino T, Ishikura S, Kawashima M, Nishimura H, Arahira S, Onozawa M.

Jpn J Clin Oncol. 2005 Dec;35(12):745-52.

PMID:
16314345
17.

Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.

Mendenhall NP, Hoppe BS, Nichols RC, Mendenhall WM, Morris CG, Li Z, Su Z, Williams CR, Costa J, Henderson RH.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):596-602. doi: 10.1016/j.ijrobp.2013.11.007.

PMID:
24521677
18.

Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.

Yoon M, Ahn SH, Kim J, Shin DH, Park SY, Lee SB, Shin KH, Cho KH.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1477-85. doi: 10.1016/j.ijrobp.2009.07.011.

PMID:
19879701
19.

Response.

Yu JB, Soulos PR, Herrin J, Cramer LD, Roberts KB, Gross CP.

J Natl Cancer Inst. 2013 May 15;105(10):748-9. No abstract available.

PMID:
23814886
20.

[Proton therapy for localized prostate cancer].

Takagi M, Demizu Y, Okimoto T.

Nihon Rinsho. 2016 May 20;74 Suppl 3:552-6. Japanese. No abstract available.

PMID:
27344792
Items per page

Supplemental Content

Support Center